Physician profile

Mark E Larkins

Pain Medicine (Anesthesiology) · Pensacola, FL

NPI 1891831871

$938.34

in general payments reported to CMS, 2019-2025

17 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $233.60 2019-2020
Stimwave Technologies Incorporated $108.79 2019
Nevro Corp. $105.11 2019-2022
Teva Pharmaceuticals USA, INC. $75.33 2019
Scilex Pharmaceuticals INC. $70.92 2019
Horizon Therapeutics Plc $62.10 2019-2022
Takeda Pharmaceuticals U.S.A., INC. $59.45 2019-2020
Biodelivery Sciences International, INC. $50.05 2019
Medtronic, INC. $28.75 2021
Boston Scientific Corporation $28.38 2019-2022
Nalu Medical, INC. $22.06 2021
Amgen INC. $20.42 2021
Allergan, INC. $18.07 2021
Medtronic USA, INC. $17.33 2020
Orthogenrx INC. $13.93 2020
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Collegium Pharmaceutical, INC. $12.80 2019
Flowonix Medical Incorporated $11.25 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Mark E Larkins

$938.34

in general payments reported 2019-2025

Years
2019-2022
Top company
Abbott Laboratories

https://glasscript.com/doctor/176681/mark-e-larkins

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.